Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine – CME Activity

public

In this JN Learning CME activity on the AMA Ed Hub, you will gain an understanding of how to reassure the public and clinical community about the scientific review and approval of a COVID-19 vaccine.  Read a September 10, 2020 JAMA Editorial by Howard Bauchner, MD; Preeti N. Malani, MD, MSJ; and Joshua Sharfstein, MD, and then take a quiz to earn CME credit. 

Public perception of the review of medications and vaccines for coronavirus disease 2019 (COVID-19) has become enmeshed in politics. The pressure on the US Food and Drug Administration (FDA) and Commissioner Stephen Hahn, MD, to approve the broad use of a COVID-19 vaccine in the coming months will be immense. However, a lack of clarity about the agency’s approach—coupled with a stream of announcements from various federal agencies and pharmaceutical companies—has led to confusion and concern. Greater clarity and transparency about the review process as well as the full engagement of the relevant federal advisory committees can inspire understanding and trust. To learn more, access the activity on JN Learning or read the Full JAMA editorial through the links below.  

LINK: JN Learning CME Activity on AMA Ed Hub  
LINK: Read the full JAMA editorial here. 

Share

Back to listing